AFT PHARMACEUTICALS LIMITED — Share Issue/Capital Change 2021

Dec 6, 2021

==> picture [159 x 86] intentionally omitted <==

Capital Change Notice

7 December 2021

Issue of ordinary shares

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.

Section 1: Issuer information

Section 1: Issuer information
Name of issuerNZX ticker codeClass of financial productISIN (If unknown, check on NZX website)CurrencySection 2: Capital change detailsNumber of issuances to which this notice relatesNumber issuedNominal value (if any)Issue price per securityNature of the paymentAmount paid up (if not in full)Percentage of total class of Financial Products issued(calculated on the number of Financial Products of theClass, excluding any Treasury Stock, in existence)For an issue of Convertible Financial Products orOptions, the principal terms of ConversionReason for issue and specific authority for issue	AFT Pharmaceuticals LimitedAFTOrdinary sharesNZAFTE0001S4NZDTwo(1) 1,250(2) 7,135Not applicable(1) $2.80(2) $2.80(1) Cash(2) Not applicableIn full0.008%Not applicable(1) Issue of 1,250 ordinary shares uponexercise of 1,250 options under theAFT Pharmaceuticals Limited LongTerm Incentive Plan(2) Issue of 7,135 ordinary shares uponcancellation of 18,750 options underthe AFT Pharmaceuticals Limited LongTerm Incentive Plan
Total number of Financial Products of the Class afterthe issue (excluding Treasury Stock) and the total	104,697,260

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com

	number of Financial Products of the Class held asTreasury Stock after the issue.	number of Financial Products of the Class held asTreasury Stock after the issue.
	Specific authority for the issue, including a referenceto the rule pursuant to which the issue is made		Directors’ resolution, Listing Rule 4.6
	Terms or details of the issue (for example: restrictions,escrow arrangements)		The ordinary shares issued rank paripassu with the existing ordinary shares
	Date of issue		7 December 2021
	Section 3: Authority for this announcement and contact person
	Section 3: Authority for this	announcement and contact p		erson
	Name of person authorised toannouncement	make this	Malc	olm Tubby
	Contact person for this annou	ncement	Malc	olm Tubby
	Contact phone number		+64	9 488 0232
	Contact email address		malc
				olm@aftpharm.com
Date of release through MAP	Date of release through MAP		7 Se	ptember 2021

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com